Experimental Hematology
Volume 37, Issue 9 , Pages 1121-1130 , September 2009

A proof of concept study: Human C48-placenta immunoregulatory factor is an effective, single therapeutic agent enabling allogeneic, nonmanipulated murine bone marrow transplantation

  • Chaya Moroz

      Affiliations

    • Laboratory of Molecular Immunology, Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel
    • Corresponding Author InformationOffprint requests to: Chaya Moroz, Ph.D., Molecular Immunology Unit, Felsenstein Research Center, Rabin Medical Center, Beilinson Campus, Petach Tikva 49100, Israel
    • ,
  • Leonid Traub

      Affiliations

    • Laboratory of Molecular Immunology, Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel
    • ,
  • Esther Rabizadeh

      Affiliations

    • Hemato-Oncology Laboratory, Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Muayad A. Zahalka

      Affiliations

    • Laboratory of Molecular Immunology, Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel

Received 5 May 2009 ,Revised 8 June 2009 ,Accepted 9 June 2009.

References 

  1. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285:412–415
  2. Oppenheim JJ. Cytokines: past, present and future. Int J Hematol. 2001;74:3–8
  3. Zhang Y, Louboutin JP, Zhu J, Rivera AJ, Emerson SG. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest. 2002;109:1335–1344
  4. Tafuri A, Alferink J, Möller P, Hämmerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. 1995;270:630–633
  5. Fournel S, Aguerre-Girr M, Huc X, et al. Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol. 2000;164:6100–6104
  6. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266–271
  7. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191–1193
  8. Moroz C, Traub L, Maymon R, Zahalka MA. PLIF: a novel human ferritin subunit from placenta with immunosuppressive activity. J Biol Chem. 2002;277:12901–12905
  9. Zahalka MA, Barak V, Traub L, Moroz C. PLIF induces IL-10 production in monocytes: a calmodulin-p38 mitogen-activated protein kinase-dependent pathway. FASEB J. 2003;17:955–957
  10. Weinberger A, Halpern M, Zahalka MA, Quintana F, Traub L, Moroz C. Placental immodulator ferritin, a novel mmunoregulator, suppresses experimental arthritis. Arthritis Rheum. 2003;48:846–853
  11. Maymon R, Bahari C, Ch Moroz. Placental isoferritin measured by a specific monoclonal antibody as a new predictive marker for premature contraction outcome. Obstet Gynecol. 1989;74:1–3
  12. Nahum R, Brenner O, Zahalka MA, Traub L, Quintana F, Moroz C. Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome. Hum Reprod. 2004;19:715–722
  13. Moroz C, Grunspan A, Zhalka MA, Traub L, Kodman Y, Yaniv I. Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks. Exp Hematol. 2006;34:159–166
  14. Yolcu ES, Askenasy N, Singh N, et al. Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity. 2002;164:161–167
  15. Askenasy N, Stein J, Yaniv I, et al. The topologic and chronologic patterns of hematopoietic cell seeding in host femoral bone marrow after transplantation. Biol Blood Marrow Transplant. 2003;9:496–504
  16. Askenasy N, Farkas DL. In vivo imaging studies of the effect of recipient conditioning, donor cell phenotype and antigen disparity on homing of hematopoietic cells to the bone marrow. Br J Haematol. 2003;120:505–515
  17. Blazar BR, Taylor PA, Snover DC, Sehgal SN, Vallera DA. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. J Immunol. 1993;151:5726–5741
  18. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray G, Vallera DA. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood. 1995;85:2607–2618
  19. Fontaine P, Perreault C. Diagnosis of graft-versus-host disease in mice transplanted across minor histocompatibility barriers. Transplantation. 1990;49:1177–1179
  20. Weiden PL. Allogeneic bone marrow transplantation [review]. Crit Rev Clin Lab Sci. 1983;19:173–186
  21. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease [review]. Biol Blood Marrow Transplant. 1999;5:347–356
  22. Moroz C, Livni E, Segal J. Treatment of recurrent spontaneous abortions by immunization with paternal lymphocytes induces immunosuppression by placental isoferritin. Am J Reprod Immunol. 1993;30:32–36
  23. Sirota L, Kupfer B, Moroz C. Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol. 1989;77:257–262
  24. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 2001;166:3789–3796
  25. Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996;184:19–29
  26. Zeller JC, Panoskaltsis-Mortari A, Murphy WJ, et al. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol. 1999;163:3684–3691
  27. Moore KW, O'Garra A. de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10 [review]. Annu Rev Immunol. 1993;11:165–190
  28. Chen ZM, O'Shaughnessy MJ, Gramaglia I, et al. IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood. 2003;101:5076–5083Epub 2003 Feb 27
  29. Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–742

PII: S0301-472X(09)00212-4

doi: 10.1016/j.exphem.2009.06.002

Experimental Hematology
Volume 37, Issue 9 , Pages 1121-1130 , September 2009

Article Tools

* Image Usage & Resolution